BENEDICTA PONGO: Open Payments
NPI 1275260176 · FRANKLIN, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,016 in 115 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $678 · 2025 $2,016
Food & beverage: $2,016
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 17 | $358 |
| Novo Nordisk Inc | 15 | $230 |
| AstraZeneca Pharmaceuticals LP | 9 | $221 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 9 | $210 |
| GlaxoSmithKline, LLC. | 8 | $185 |
| ABBVIE INC. | 19 | $177 |
| Amgen Inc. | 9 | $144 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $119 |
| Viatris Specialty LLC | 7 | $101 |
| PFIZER INC. | 5 | $81 |
Products named: XIFAXAN, JARDIANCE, TRELEGY ELLIPTA, MOUNJARO, Kerendia, Ozempic, QULIPTA, YUPELRI.
Industry payments across NC — which companies pay providers there.
